Joy Lin is a visionary leader with over 15 years of experience in the pharma, biotech, and medtech industries, currently serving as the Director of the HIV, COVID, and Antifungal Business Unit at Gilead Sciences. Prior roles include Associate Director of Corporate Strategy at Eisai Co., Ltd., where they spearheaded global product launches, and Business Manager for Cosentyx at Novartis, leading a high-performing commercial team. Joy has a proven track record in managing multi-million-dollar portfolios and establishing strategic partnerships to enhance healthcare outcomes in Asia markets. They hold a degree from Imperial College London.
This person is not in any teams
This person is not in any offices